Sign In
Buy DRIO
$7.50
-0.1000 (-1.32%)
At Close: Jun 05, 2026
Regional Union Selects Dario's Cardiometabolic Solution for Diabetes, Hypertension, Weight Management and GLP-1 Support
08:30am, Thursday, 11'th Jan 2024
Dario's integrated solution to support improved whole health gains traction in public and labor market NEW YORK , Jan. 11, 2024 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Compa
National Employer Selects Dario Cardiometabolic and GLP-1 Solutions to Improve Employee Health
08:30am, Tuesday, 05'th Dec 2023
New client will use Dario's integrated approach to support long-term behavior change for employees living with diabetes, pre-diabetes, hypertension and those taking a GLP-1 medication NEW YORK , Dec.
Blue Shield of California's Award-Winning Wellvolution Now More Accessible for Spanish Speakers, Adds New Hypertension Offering
11:00am, Wednesday, 29'th Nov 2023
Nonprofit health plan expands services to better meet the healthcare needs of Californians by making it easier to enroll in lifestyle medicine programs at no additional cost OAKLAND, Calif. , Nov. 29,
Dario Contracts with New Employer for Cardiometabolic Solution
08:30am, Monday, 27'th Nov 2023
Demand for Dario's integrated cardiometabolic solution continues to grow as employers grappling with the surge in GLP-1 medication utilization search for proven ways to change health behaviors NEW YOR
New Research Sheds Light on Mediators of Improved Outcomes in Dario Users
08:30am, Tuesday, 21'st Nov 2023
Two new analyses associate improved clinical and economic outcomes with use of Dario's digital health solution NEW YORK , Nov. 21, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the
Dario Publishes New Research Demonstrating that Dario Users That Increased Physical Activity Can Maintain Reduced Blood Glucose
08:30am, Monday, 13'th Nov 2023
New study highlights the value of a whole health approach managing chronic conditions and supporting members using GLP-1s NEW YORK , Nov. 13, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Da
DarioHealth Disappoints, But A Better Future Is Ahead
04:39am, Tuesday, 03'rd Oct 2023
DarioHealth has experienced a disappointing year with stalled revenue growth and a decline in new customer wins. However, H2/23 and FY24 are expected to bring improved financials, including revenue gr
DarioHealth is an AI-Powered Digital Therapeutics Play
08:36am, Tuesday, 13'th Jun 2023
DarioHealth Co. NASDAQ: DRIO is an AI-powered digital therapeutics platform and provider that adaptively personalizes monitoring and treatments for chronic diseases. The mobile app manages five common
DarioHealth Corp. (DRIO) Q1 2023 Earnings Call Transcript
03:34pm, Thursday, 11'th May 2023
DarioHealth Corp. (NASDAQ:DRIO ) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Chuck Padala - Managing Director, Investor Relations Erez Raphael - Chief Executive Offic
DarioHealth Corp. (DRIO) Q4 2022 Results Conference Call
02:06pm, Thursday, 09'th Mar 2023
DarioHealth Corp. (NASDAQ:DRIO ) Q4 2022 Results Conference Call March 9, 2023 8:30 PM ET Company Participants Glenn Garmont - Investor Relations Erez Raphael - Chief Executive Officer Rick Anderson -
DarioHealth to Report Fourth Quarter 2022 Results on Thursday, March 9th
08:00am, Thursday, 02'nd Mar 2023
Company to host conference call and webcast at 8:30 am ET NEW YORK , March 2, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today ann
DarioHealth: January Rally Looks To Be Exhausting (Technical Analysis)
02:37am, Thursday, 02'nd Feb 2023
DarioHealth rallied off a low in December and since raced to new highs. Market generated data suggests the rally could extend over the coming weeks to months.
DarioHealth: Market Sentiment Shift Post Q3 Numbers, Revise To Speculative Buy
11:44am, Thursday, 17'th Nov 2022
We've revised our rating on DarioHealth to a buy, with consideration to tactical allocation for equity portfolios. DRIO's Q3 numbers came in strong with upsides versus consensus at the top and bottom
DarioHealth Corp. (DRIO) Q3 2022 Earnings Call Transcript
12:14pm, Tuesday, 15'th Nov 2022
DarioHealth Corp. (NASDAQ:DRIO ) Q3 2022 Results Conference Call November 15, 2022 8:30 AM ET Company Participants Glenn Garmont - IR Erez Raphael - CEO Rick Anderson - President Conference Call Parti
US Stocks Open Higher Ahead Of Fed Decision, Dow Jumps 175 Points
02:15pm, Wednesday, 21'st Sep 2022 Benzinga
U.S. stocks traded higher this morning, with the Dow Jones gaining around 175 points on Wednesday. The Federal Reserve will announce its policy decision at 2:00 p.m. ET. The country’s central bank i
